Rallis India Q1 profit jumps 31% to ₹125 crore as Crop Care and Seeds revenue rise
Rallis India’s Q1 revenue grew 7% to ₹1,022 crore and EBITDA rose 23% to ₹184 crore. Crop Care B2C growth of 19% offset a 19% B2B decline, while the company launched three Crop Care and nine seed products.
What happened
Rallis India reported strong Q1 growth, led by domestic formulation and B2C Crop Care demand, while launching new crop-protection, soil-health and seed products
Key facts
- Net profit ₹125 crore, up 31% from ₹95 crore
- Revenue ₹1,022 crore, up 7% from ₹957 crore
- EBITDA ₹184 crore, up 23% from ₹150 crore
- Crop Care revenue ₹697 crore, up 7%
- Crop Care B2C growth 19%
- Crop Care B2B decline 19%
- Soil & Plant Health growth 10%
- Seeds revenue ₹325 crore, up 6%
- Three Crop Care products launched
- Nine new seed products launched
Why this matters
Rallis India’s launch of three Crop Care and nine seed products, alongside rising Seeds and B2C revenue, strengthens its platform for targeted growth partnerships.
What to watch
- Upcoming monsoon distribution and sowing-area data
- Q2 Crop Care B2C and B2B revenue growth
- Seeds volume growth and repeat purchases of newly launched products
- Gross margin and EBITDA margin progression
- Dealer inventory, receivables and working-capital trends
- Peer earnings from UPL, PI Industries, Coromandel and Bayer CropScience India
- Re-rate near-term earnings expectations modestly, while separating consumer-facing Crop Care momentum from the weaker B2B business.
- Track whether distributors and retailers increase inventory after the product launches, particularly across Seeds and B2C Crop Care.
- Compare Rallis performance with peers to assess whether the result reflects company-specific execution or a broader recovery in Indian agri-input demand.
- Watch for management commentary on pricing, gross margins, channel inventory and the sustainability of the 23% EBITDA increase.
Also reported by
- BL · Consumer & Economy — Same time